Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia

Ethiopian Medical Journal

Volumn 44, Issue 3, 2006, Pages 237-244

  Tadios, Yonas ^a   Davey, Gail ^a  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; CROSS-SECTIONAL STUDY; DEPRESSION; EPIDEMIOLOGY; ETHIOPIA; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; REVIEW; STATISTICS; UTILIZATION REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; DEPRESSION; ETHIOPIA; FEMALE; HEALTH CARE SURVEYS; HIV INFECTIONS; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 33845777486     PISSN: 00141755     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Ammassari A, Trotta MP, Mul R et al. Correlates and Predictors of Adherence to HAART. JAIDS 2002;31: S123-S7.
2. Bartlett JA. Addressing the challenges of Adherence. JAIDS 2002;29:S2-S10.
3. O'Hanrahan M, O'Malley K. Compliance with drug treatment. BMJ: 1981;283:298-300.
4. Ickovics JR, Meade CS. Adherence to Antiretroviral Therapy Among Patients With HIV: A Critical Link Between Behavioral and Biomedical Sciences. JAIDS 2002;31:98-102
5. Best practices in the Behavioral Management of Chronic Disease (Volume II, Chapter 3), Institute for Disease Management, Los Altos, CA.
6. Raven Press, Ltd., New York. HIV Dementia Scale: A Rapid Screening Test. JAIDS. 1995;8:273-8.
7. Gifford AL, Bormann JE, Shively MJ et al. Predictors of self reported adherence and plasma HIV concentrations in patient on multidrug antiretroviral regimens. JAIDS 2000;23:386-95.
8. Oreel C, Bangsberg D, Badri M. et al. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 2003;17:1369-75.
9. th conference on Retroviruses and Opportunistic Infections, Boston, February 2003.
10. th conference on Retroviruses and Opportunistic Infections, Boston, February 2003.
11. Mehta S et al. Potential factors affecting adherence with HIV therapy. AIDS 1997;11:1665-70.
12. Singh N, Berman SM, Swindells S, et al. Adherence of human immune deficiency virus infected patients to antiretroviral therapy. Clin Infect Dis 1999;29:824-30.
13. Kleeberger CA, Phair JP, Strathdee SA, et al. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study. JAIDS 2001;26:82-92.
14. Ammassari A, Murri R, Pezzoti P et al. Self reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. JAIDS 2001;28:445-9.
15. Lewis RK, Lasack NL, Lambert BL, & Connor SE (1997). Patient counseling - a focus on maintenance therapy. American Journal of Health-Systems Pharmacists, 54, 2084-98.
16. Catz SL, Kelly JA, Bogart LM, et al. Patterns correlates and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000;19:124-33.
17. Eldred LJ, Wu AW, Chaisson RE, et al. Adherence to antiretrovirals and pneumocystis prophylaxis in HIV disease. JAIDS 1998;18:117-25.